Advanced search
Publication Cover
Substance Abuse Volume 41, 2020 - Issue 1
Journal homepage
670
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?

Ajay ManhapraVA New England Mental Illness Research and Education Center, West Haven, Connecticut, USA; ;Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA; ;Advanced PACT Pain Clinic, VA Hampton Medical Center, Hampton, Virginia, USA; ;Department of Physical Medicine and Rehabilitation, Eastern Virginia Medical School, Norfolk, Virginia, USA; ;Department of Psychiatry, Eastern Virginia Medical School, Norfolk, Virginia, USACorrespondence[email protected]
View further author information
, MD,
Elina StefanovicsVA New England Mental Illness Research and Education Center, West Haven, Connecticut, USA; ;Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA; View further author information
, PhD &
Robert RosenheckVA New England Mental Illness Research and Education Center, West Haven, Connecticut, USA; ;Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA; View further author information
, MD
Pages 110-120 | Published online: 12 Aug 2019

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Alex S. Bennett, Honoria Guarino, Peter C. Britton, Dan O’Brien-Mazza, Stephanie H. Cook, Franklin Taveras, Juan Cortez & Luther Elliott. (2022) U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts. Annals of Medicine 54:1, pages 1826-1838.
Read now
Kelsey C. Priest, Caroline A. King, Honora Englander, Travis I. Lovejoy & Dennis McCarty. (2022) Differences in the delivery of medications for opioid use disorder during hospitalization by racial categories: A retrospective cohort analysis. Substance Abuse 43:1, pages 1251-1259.
Read now
Rachel K. Landis, Jonathan S. Levin, Brendan Saloner, Adam J. Gordon, Andrew W. Dick, Tisamarie B. Sherry, Douglas L. Leslie, Mark Sorbero & Bradley D. Stein. (2022) Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine. Substance Abuse 43:1, pages 1057-1071.
Read now

Articles from other publishers (25)

Madeline C. Frost, Carol A. Malte, Eric J. Hawkins, Joseph E. Glass, Kevin A. Hallgren & Emily C. Williams. (2023) Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders. Journal of Substance Use and Addiction Treatment 155, pages 209175.
Crossref
T. Lance Tippit, Megan A. O’Connell, Ryan C. Costantino, Maya Scott-Richardson, Sidney Peters, Jennifer Pakieser, Laura C. Tilley & Krista B. Highland. (2023) Racialized and beneficiary inequities in medication to treat opioid use disorder receipt within the US Military Health System. Drug and Alcohol Dependence 253, pages 111025.
Crossref
Rachel P. Winograd, Bridget Coffey, Melissa Nance & Ryan Carpenter. (2023) The association of medical providers’ attitudes about naloxone and treating people with opioid use disorder and their self-reported low-barrier treatment practices. Addictive Behaviors Reports 18, pages 100514.
Crossref
Ryan R. Cook, Erin N. Jaworski, Kim A. Hoffman, Elizabeth N. Waddell, Renae Myers, P. Todd Korthuis & Pamela Vergara-Rodriguez. (2023) Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder. Substance Abuse.
Crossref
Rachel Winograd, Zach Budesa, Devin Banks, Ryan Carpenter, Claire A. Wood, Alex Duello, Paul Thater & Christine Smith. (2023) Outcomes of State Targeted/Opioid Response Grants and the Medication First Approach: Evidence of Racial Inequities in Improved Treatment Access and Retention. Substance Abuse.
Crossref
Aline M. Lott, Anissa N. Danner, Carol A. Malte, Emily C. Williams, Adam J. Gordon, Max A. Halvorson, Andrew J. Saxon, Hildi J. Hagedorn, George G. Sayre & Eric J. Hawkins. (2023) Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation. Journal of Addiction Medicine 17:4, pages e262-e268.
Crossref
Adam J. Gordon, Andrew J. Saxon, Stefan Kertesz, Jessica J. Wyse, Ajay Manhapra, Lewei A. Lin, Wei Chen, Jared Hansen, Derek Pinnell, Tina Huynh, Jacob D. Baylis, Francesca E. Cunningham, Udi E. Ghitza, Gavin Bart, Hong Yu & Brian C. Sauer. (2023) Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug and Alcohol Dependence 248, pages 109902.
Crossref
Megan S. Schuler, Brendan Saloner, Adam J. Gordon, Andrew W. Dick & Bradley D. Stein. (2023) National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018. Substance Abuse, pages 088970772311795.
Crossref
Madeline C. Frost, Eric J. Hawkins, Joseph E. Glass, Kevin A. Hallgren & Emily C. Williams. (2023) Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of Addiction Medicine 17:3, pages 278-285.
Crossref
R. R. Cook, C. Foot, O. A. Arah, K. Humphreys, K. E. Rudolph, S. X. Luo, J. I. Tsui, X. A. Levander & P. T. Korthuis. (2023) Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations. Addiction Science & Clinical Practice 18:1.
Crossref
Thomas SantoJr.Jr., Natasa Gisev, Gabrielle Campbell, Elliot Nelson & Louisa Degenhardt. (2023) The effects of childhood trauma and mental disorders on treatment engagement, contact with the criminal justice system, and mortality among people with opioid dependence. Drug and Alcohol Dependence 243, pages 109734.
Crossref
Elizabeth J. Austin, Elsa S. Briggs, Lori Ferro, Paul Barry, Ashley Heald, Geoffrey M. Curran, Andrew J. Saxon, John Fortney, Anna D. Ratzliff & Emily C. Williams. (2022) Integrating Routine Screening for Opioid Use Disorder into Primary Care Settings: Experiences from a National Cohort of Clinics. Journal of General Internal Medicine 38:2, pages 332-340.
Crossref
Madeline C. Frost, Lan Zhang, H. Myra Kim & Lewei (Allison) Lin. (2022) Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic. JAMA Network Open 5:10, pages e2236298.
Crossref
Madeline C. Frost, Julie E. Richards, John R. Blosnich, Eric J. Hawkins, Judith I. Tsui, E. Jennifer Edelman & Emily C. Williams. (2022) Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder. Drug and Alcohol Dependence 237, pages 109521.
Crossref
O. Trent Hall, Nia M. Bhadra-Heintz, Julie Teater, Jennifer Samiec, Jose Moreno, Kamilah Dixon-Shambley, Kara M. Rood, David A. Fiellin & Ayana Jordan. (2022) Group-based medical mistrust and care expectations among black patients seeking addiction treatment. Drug and Alcohol Dependence Reports 2, pages 100026.
Crossref
O. Trent Hall, Ayana Jordan, Julie Teater, Kamilah Dixon-Shambley, Monique E. McKiever, Mikyung Baek, Stephanie Garcia, Kara M. Rood & David A. Fielin. (2022) Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment. Journal of Substance Abuse Treatment 133, pages 108551.
Crossref
Madeline C. Frost, Hannah Lampert, Judith I. Tsui, Matthew D. Iles-Shih & Emily C. Williams. (2021) The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addiction Science & Clinical Practice 16:1.
Crossref
Alexandria Macmadu, Kimberly Paull, Rouba Youssef, Sivakumar Batthala, Kevin H. Wilson, Elizabeth A. Samuels, Jesse L. Yedinak & Brandon D.L. Marshall. (2021) Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study. Drug and Alcohol Dependence 226, pages 108890.
Crossref
Megan S. Schuler, Andrew W. Dick & Bradley D. Stein. (2021) Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017. Drug and Alcohol Dependence 223, pages 108710.
Crossref
Benjamin A. Howell, Erica A. Abel, Dongchan Park, Sara N. Edmond, Leah J. Leisch & William C. Becker. (2020) Validity of Incident Opioid Use Disorder (OUD) Diagnoses in Administrative Data: a Chart Verification Study. Journal of General Internal Medicine 36:5, pages 1264-1270.
Crossref
Alexandria Macmadu, Kimberly Paull, Rouba Youssef, Sivakumar Batthala, Kevin H. Wilson, Elizabeth A. Samuels, Jesse L. Yedinak & Brandon D.L. Marshall. (2021) Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study. Drug and Alcohol Dependence 219, pages 108435.
Crossref
Kelsey C. Priest. (2020) Commentary on Jin et al . (2020): Regulatory and allocative policies inform access to opioid agonist therapy . Addiction 115:12, pages 2255-2256.
Crossref
Perry Xu, Edward Choi, Farouk M. El-Khatib, Emily Choe & Faysal Yafi. (2020) Sexual Dysfunction in Persons Receiving Opioid Substitution Therapy. Current Sexual Health Reports 12:4, pages 371-380.
Crossref
Kelsey C. Priest, Dennis McCarty & Travis I. Lovejoy. (2020) Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration. Journal of General Internal Medicine 35:S3, pages 886-890.
Crossref
Katherine Mackey, Stephanie Veazie, Johanna Anderson, Donald Bourne & Kim Peterson. (2020) Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review. Journal of General Internal Medicine 35:S3, pages 954-963.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.